{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:05:40Z","timestamp":1791392740424,"version":"4.3.3"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science and Technology Research Project of Chongqing Education Commission","award":["KJQN202100416"],"award-info":[{"award-number":["KJQN202100416"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00044-026-03570-1","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T08:16:12Z","timestamp":1777104972000},"page":"876-902","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A comprehensive review of 11C-, 18F-, and 123\/124\/125I-labeled radiotracers targeting cyclooxygenase-2 over the past two decades"],"prefix":"10.1007","volume":"35","author":[{"given":"Jianhua","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"3570_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","volume":"69","author":"WL Smith","year":"2000","unstructured":"Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases. Structural, Cellular, and Molecular Biology. Annu Rev Biochem. 2000;69:145\u201382. . https:\/\/doi.org\/10.1146\/annurev.biochem.69.1.145","journal-title":"Annu Rev Biochem"},{"issue":"28","key":"3570_CR2","doi-asserted-by":"publisher","first-page":"16737","DOI":"10.1016\/S0021-9258(17)44821-6","volume":"265","author":"JY Fu","year":"1990","unstructured":"Fu JY, Masferrer JL, Seibert K, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 1990;265(28):16737\u201340. https:\/\/doi.org\/10.1016\/S0021-9258(17)44821-6.","journal-title":"J Biol Chem"},{"key":"3570_CR3","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","volume":"50","author":"CA Rouzer","year":"2009","unstructured":"Rouzer CA, Marnett LJ. Cyclooxygenases: structural and functional insights. J Lipid Res. 2009;50:S29\u201334. https:\/\/doi.org\/10.1194\/jlr.R800042-JLR200.","journal-title":"J Lipid Res"},{"issue":"4","key":"3570_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3892\/ijmm.6.4.455","volume":"6","author":"T Okamoto","year":"2000","unstructured":"Okamoto T, Hino O. Expression of cyclooxygenase-1 and \u2013\u20092 mRNA in rat tissues: tissue-specific difference in the expression of the basal level of mRNA. Int J Mol Med. 2000;6(4):455\u201362. https:\/\/doi.org\/10.3892\/ijmm.6.4.455.","journal-title":"Int J Mol Med"},{"issue":"25","key":"3570_CR5","doi-asserted-by":"publisher","first-page":"12013","DOI":"10.1073\/pnas.91.25.12013","volume":"91","author":"K Seibert","year":"1994","unstructured":"Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci. 1994;91(25):12013\u20137. https:\/\/doi.org\/10.1073\/pnas.91.25.12013.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"3570_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tips.2009.01.002","volume":"30","author":"S-H Choi","year":"2009","unstructured":"Choi S-H, Aid S, Bosetti F. The distinct roles of cyclooxygenase-1 and \u2013\u20092 in neuroinflammation: implications for translational research. Trends Pharmacol Sci. 2009;30(4):174\u201381. https:\/\/doi.org\/10.1016\/j.tips.2009.01.002.","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"3570_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0006-8993(02)03164-5","volume":"951","author":"JJM Hoozemans","year":"2002","unstructured":"Hoozemans JJM, Veerhuis R, Janssen I, van Elk E-J, Rozemuller AJM, Eikelenboom P. The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E2 secretion by cultured human adult microglia: Implications for Alzheimer\u2019s disease. Brain Res. 2002;951(2):218\u201326. https:\/\/doi.org\/10.1016\/S0006-8993(02)03164-5.","journal-title":"Brain Res"},{"issue":"2","key":"3570_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainresrev.2006.02.002","volume":"52","author":"JW Phillis","year":"2006","unstructured":"Phillis JW, Horrocks LA, Farooqui AA. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: Their role and involvement in neurological disorders. Brain Res Rev. 2006;52(2):201\u201343. https:\/\/doi.org\/10.1016\/j.brainresrev.2006.02.002.","journal-title":"Brain Res Rev"},{"issue":"6","key":"3570_CR9","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/onc.2009.421","volume":"29","author":"D Wang","year":"2010","unstructured":"Wang D, DuBois RN. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene. 2010;29(6):781\u20138. https:\/\/doi.org\/10.1038\/onc.2009.421.","journal-title":"Oncogene"},{"issue":"9","key":"3570_CR10","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1073\/pnas.0837397100","volume":"100","author":"P Teismann","year":"2003","unstructured":"Teismann P, Tieu K, Choi D-K, Wu D-C, Naini A, Hunot S, et al. Cyclooxygenase-2 is instrumental in Parkinson\u2019s disease neurodegeneration. Proc Natl Acad Sci. 2003;100(9):5473\u20138. https:\/\/doi.org\/10.1073\/pnas.0837397100.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"3570_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/jcp.55.6.429","volume":"55","author":"C Costa","year":"2002","unstructured":"Costa C, Soares R, Reis-Filho JS, Leit\u00e3o D, Amendoeira I, Schmitt FC. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol. 2002;55(6):429. https:\/\/doi.org\/10.1136\/jcp.55.6.429.","journal-title":"J Clin Pathol"},{"issue":"1","key":"3570_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.critrevonc.2006.01.003","volume":"59","author":"J-B M\u00e9ric","year":"2006","unstructured":"M\u00e9ric J-B, Rottey S, Olaussen K, Soria J-C, Khayat D, Rixe O, et al. Cyclooxygenase-2 as a target for anticancer drug development. Crit Rev Oncol\/Hematol. 2006;59(1):51\u201364. https:\/\/doi.org\/10.1016\/j.critrevonc.2006.01.003.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"24","key":"3570_CR13","doi-asserted-by":"publisher","first-page":"8465","DOI":"10.1158\/1078-0432.CCR-04-0653","volume":"10","author":"LT Soumaoro","year":"2004","unstructured":"Soumaoro LT, Uetake H, Higuchi T, Takagi Y, Enomoto M, Sugihara K. Cyclooxygenase-2 Expression: A Significant Prognostic Indicator for Patients With Colorectal Cancer. Clin Cancer Res. 2004;10(24):8465\u201371. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0653.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"3570_CR14","doi-asserted-by":"publisher","first-page":"e21051","DOI":"10.1016\/j.heliyon.2023.e21051","volume":"9","author":"A Purnama","year":"2023","unstructured":"Purnama A, Lukman K, Rudiman R, Prasetyo D, Fuadah Y, Nugraha P, et al. The prognostic value of COX-2 in predicting metastasis of patients with colorectal cancer: A systematic review and meta analysis. Heliyon. 2023;9(10):e21051. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21051.","journal-title":"Heliyon"},{"issue":"3","key":"3570_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"A Greenhough","year":"2009","unstructured":"Greenhough A, Smartt HJM, Moore AE, Roberts HR, Williams AC, Paraskeva C, et al. The COX-2\/PGE 2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 2009;30(3):377\u201386. https:\/\/doi.org\/10.1093\/carcin\/bgp014.","journal-title":"Carcinogenesis"},{"issue":"4","key":"3570_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jlcr.3160","volume":"57","author":"A Pacelli","year":"2014","unstructured":"Pacelli A, Greenman J, Cawthorne C, Smith G. Imaging COX-2 expression in cancer using PET\/SPECT radioligands: current status and future directions. J Label Compd Radiopharm. 2014;57(4):317\u201322. https:\/\/doi.org\/10.1002\/jlcr.3160.","journal-title":"J Label Compd Radiopharm"},{"issue":"30","key":"3570_CR17","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.2174\/138161206778559650","volume":"12","author":"Vries EFJd","year":"2006","unstructured":"Vries EFJd. Imaging of Cyclooxygenase-2 (COX-2) Expression: Potential Use in Diagnosis and Drug Evaluation. Curr Pharm Design. 2006;12(30):3847\u201356. https:\/\/doi.org\/10.2174\/138161206778559650.","journal-title":"Curr Pharm Design"},{"key":"3570_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/molecules18066311","author":"M Laube","year":"2013","unstructured":"Laube M, Kniess T, Pietzsch J. Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity \u2014 A Critical Update. Molecules. 2013. https:\/\/doi.org\/10.3390\/molecules18066311.","journal-title":"Molecules"},{"issue":"35","key":"3570_CR19","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.2174\/09298673113206660260","volume":"20","author":"O Tietz","year":"2013","unstructured":"Tietz O, Marshall A, Wuest M, Wang M, Wuest F. Radiotracers for Molecular Imaging of Cyclooxygenase-2 (COX-2) Enzyme. Curr Med Chem. 2013;20(35):4350\u201369. https:\/\/doi.org\/10.2174\/09298673113206660260.","journal-title":"Curr Med Chem"},{"issue":"12","key":"3570_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/jlcr.1002","volume":"48","author":"J Prabhakaran","year":"2005","unstructured":"Prabhakaran J, Majo VJ, Simpson NR, Van Heertum RL, Mann JJ, Kumar JSD. Synthesis of [11C]celecoxib: a potential PET probe for imaging COX-2 expression. J Label Compd Radiopharm. 2005;48(12):887\u201395. https:\/\/doi.org\/10.1002\/jlcr.1002.","journal-title":"J Label Compd Radiopharm"},{"issue":"9","key":"3570_CR21","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1016\/j.bmc.2011.03.020","volume":"19","author":"M Takashima-Hirano","year":"2011","unstructured":"Takashima-Hirano M, Takashima T, Katayama Y, Wada Y, Sugiyama Y, Watanabe Y, et al. Efficient sequential synthesis of PET Probes of the COX-2 inhibitor [11C]celecoxib and its major metabolite [11C]SC-62807 and in vivo PET evaluation. Bioorg Med Chem. 2011;19(9):2997\u20133004. https:\/\/doi.org\/10.1016\/j.bmc.2011.03.020.","journal-title":"Bioorg Med Chem"},{"key":"3570_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.brainres.2013.08.026","volume":"1533","author":"B Ji","year":"2013","unstructured":"Ji B, Kumata K, Onoe H, Kaneko H, Zhang M-R, Seki C, et al. Assessment of radioligands for PET imaging of cyclooxygenase-2 in an ischemic neuronal injury model. Brain Res. 2013;1533:152\u201362. https:\/\/doi.org\/10.1016\/j.brainres.2013.08.026.","journal-title":"Brain Res"},{"key":"3570_CR23","doi-asserted-by":"publisher","unstructured":"Kumar JSD, Bai B, Zanderigo F, DeLorenzo C, Prabhakaran J, Parsey RV, et al. In Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [11C]Celecoxib, a COX-2 PET Ligand, in Nonhuman Primates. Molecules. 2018;23(8). https:\/\/doi.org\/10.3390\/molecules23081929.","DOI":"10.3390\/molecules23081929"},{"issue":"7","key":"3570_CR24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/BF02985057","volume":"19","author":"Y Fujisaki","year":"2005","unstructured":"Fujisaki Y, Kawamura K, Wang W-F, Ishiwata K, Yamamoto F, Kuwano T, et al. Radiosynthesis andin vivo evaluation of 11C-Iabeled 1,5-diarylpyrazole derivatives for mapping cyclooxygenases. Ann Nucl Med. 2005;19(7):617\u201325. https:\/\/doi.org\/10.1007\/BF02985057.","journal-title":"Ann Nucl Med"},{"issue":"9","key":"3570_CR25","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1016\/j.ejmech.2011.05.024","volume":"46","author":"M Gao","year":"2011","unstructured":"Gao M, Wang M, Miller KD, Zheng Q-H. Synthesis and preliminary in vitro biological evaluation of new carbon-11-labeled celecoxib derivatives as candidate PET tracers for imaging of COX-2 expression in cancer. Eur J Med Chem. 2011;46(9):4760\u20137. https:\/\/doi.org\/10.1016\/j.ejmech.2011.05.024.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"3570_CR26","first-page":"117","volume":"43","author":"TJ McCarthy","year":"2002","unstructured":"McCarthy TJ, Sheriff AU, Graneto MJ, Talley JJ, Welch MJ, Radiosynthesis. In Vitro Validation, and In Vivo Evaluation of 18F-Labeled COX-1 and COX-2 Inhibitors. J Nucl Med. 2002;43(1):117.","journal-title":"J Nucl Med"},{"issue":"4","key":"3570_CR27","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/j.bmc.2006.11.033","volume":"15","author":"J Prabhakaran","year":"2007","unstructured":"Prabhakaran J, Underwood MD, Parsey RV, Arango V, Majo VJ, Simpson NR, et al. Synthesis and in vivo evaluation of [18F]-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide as a PET imaging probe for COX-2 expression. Bioorg Med Chem. 2007;15(4):1802\u20137. https:\/\/doi.org\/10.1016\/j.bmc.2006.11.033.","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"3570_CR28","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1158\/1940-6207","volume":"4","author":"MJ Uddin","year":"2011","unstructured":"Uddin MJ, Crews BC, Ghebreselasie K, Huda I, Kingsley PJ, Ansari MS, et al. Fluorinated COX-2 Inhibitors as Agents in PET Imaging of Inflammation and Cancer. Cancer Prev Res. 2011;4(10):1536\u201345. https:\/\/doi.org\/10.1158\/1940-6207.","journal-title":"Cancer Prev Res"},{"issue":"10","key":"3570_CR29","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/cmdc.201500287","volume":"10","author":"J Kaur","year":"2015","unstructured":"Kaur J, Tietz O, Bhardwaj A, Marshall A, Way J, Wuest M, et al. Design, Synthesis, and Evaluation of an 18F-Labeled Radiotracer Based on Celecoxib\u2013NBD for Positron Emission Tomography (PET) Imaging of Cyclooxygenase\u20102 (COX\u20102). ChemMedChem. 2015;10(10):1635\u201340. https:\/\/doi.org\/10.1002\/cmdc.201500287.","journal-title":"ChemMedChem"},{"key":"3570_CR30","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.2147\/dddt.S161718","volume":"12","author":"C-W Chang","year":"2018","unstructured":"Chang C-W, Yeh C-N, Chung Y-H, Chen Y-R, Tien S-W, Chen T-W, et al. Synthesis and evaluation of ortho-[18F]fluorocelecoxib for COX-2 cholangiocarcinoma imaging. Drug Des Devel Ther. 2018;12:1467\u201378. https:\/\/doi.org\/10.2147\/dddt.S161718.","journal-title":"Drug Des Devel Ther"},{"key":"3570_CR31","doi-asserted-by":"publisher","unstructured":"Garg P, Lebedev A, Jiao J, Lee J, Yang F, Allison N, et al. Radiochemistry on electrodes: Synthesis of an 18F-labelled and in vivo stable COX-2 inhibitor. PLoS ONE. 2017;12(5). https:\/\/doi.org\/10.1371\/journal.pone.0176606.","DOI":"10.1371\/journal.pone.0176606"},{"issue":"4","key":"3570_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/jlcr.923","volume":"48","author":"GW Kabalka","year":"2005","unstructured":"Kabalka GW, Mereddy AR, Schuller HM. Synthesis of an iodine-123\u2010labeled celecoxib analogue: a potential spect agent. J Label Compd Radiopharm. 2005;48(4):295\u2013300. https:\/\/doi.org\/10.1002\/jlcr.923.","journal-title":"J Label Compd Radiopharm"},{"issue":"6","key":"3570_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/cmdc.200500032","volume":"1","author":"HM Schuller","year":"2006","unstructured":"Schuller HM, Kabalka G, Smith G, Mereddy A, Akula M, Cekanova M. Detection of Overexpressed COX-2 in Precancerous Lesions of Hamster Pancreas and Lungs by Molecular Imaging: Implications for Early Diagnosis and Prevention. ChemMedChem. 2006;1(6):603\u201310. https:\/\/doi.org\/10.1002\/cmdc.200500032.","journal-title":"ChemMedChem"},{"issue":"1","key":"3570_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.nucmedbio.2005.10.004","volume":"33","author":"Y Kuge","year":"2006","unstructured":"Kuge Y, Katada Y, Shimonaka S, Temma T, Kimura H, Kiyono Y, et al. Synthesis and evaluation of radioiodinated cyclooxygenase-2 inhibitors as potential SPECT tracers for cyclooxygenase-2 expression. Nucl Med Biol. 2006;33(1):21\u20137. https:\/\/doi.org\/10.1016\/j.nucmedbio.2005.10.004.","journal-title":"Nucl Med Biol"},{"issue":"2","key":"3570_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1021\/ml100232q","volume":"2","author":"MJ Uddin","year":"2010","unstructured":"Uddin MJ, Crews BC, Ghebreselasie K, Tantawy MN, Marnett LJ. [123I]-Celecoxib Analogues as SPECT Tracers of Cyclooxygenase-2 in Inflammation. ACS Med Chem Lett. 2010;2(2):160\u20134. https:\/\/doi.org\/10.1021\/ml100232q.","journal-title":"ACS Med Chem Lett"},{"issue":"2","key":"3570_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10967-010-0583-8","volume":"285","author":"KM El-Azony","year":"2010","unstructured":"El-Azony KM. Preparation of 125I-celecoxib with high purity as a possible tumor agent. J Radioanal Nucl Chem. 2010;285(2):315\u201320. https:\/\/doi.org\/10.1007\/s10967-010-0583-8.","journal-title":"J Radioanal Nucl Chem"},{"issue":"10","key":"3570_CR37","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1248\/bpb.29.2087","volume":"29","author":"M Tanaka","year":"2006","unstructured":"Tanaka M, Fujisaki Y, Kawamura K, Ishiwata K, Qinggeletu, Yamamoto F, et al. Radiosynthesis and Evaluation of 11C-Labeled Diaryl-Substituted Imidazole and Indole Derivatives for Mapping Cyclooxygenase-2. Biol Pharm Bull. 2006;29(10):2087\u201394. https:\/\/doi.org\/10.1248\/bpb.29.2087.","journal-title":"Biol Pharm Bull"},{"key":"3570_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5823261","volume":"2019","author":"A Carpinelli","year":"2019","unstructured":"Carpinelli A, Rainone P, Belloli S, Reale A, Cappelli A, Germano G, et al. Radiosynthesis and Preclinical Evaluation of 11C-VA426, a Cyclooxygenase-2 Selective Ligand. Contrast Media Mol Imaging. 2019;2019:1\u201312. https:\/\/doi.org\/10.1155\/2019\/5823261.","journal-title":"Contrast Media Mol Imaging"},{"key":"3570_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-025-11328-x","author":"W Miao","year":"2025","unstructured":"Miao W, Yang M, Peng Z, Xia Z, Zhang X, Chen Y, et al. Synthesis and preclinical evaluation of an 18F-labeled 1,5-diarylpyrrole derivative for imaging of COX-2 expression. Mol Diversity. 2025. https:\/\/doi.org\/10.1007\/s11030-025-11328-x.","journal-title":"Mol Diversity"},{"issue":"11","key":"3570_CR40","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1016\/j.bmc.2012.04.022","volume":"20","author":"T Kniess","year":"2012","unstructured":"Kniess T, Laube M, Bergmann R, Sehn F, Graf F, Steinbach J, et al. Radiosynthesis of a 18F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo. Bioorg Med Chem. 2012;20(11):3410\u201321. https:\/\/doi.org\/10.1016\/j.bmc.2012.04.022.","journal-title":"Bioorg Med Chem"},{"issue":"18","key":"3570_CR41","doi-asserted-by":"publisher","first-page":"5812","DOI":"10.1002\/slct.201601618","volume":"1","author":"C Gassner","year":"2016","unstructured":"Gassner C, Neuber C, Laube M, Bergmann R, Kniess T, Pietzsch J. Development of a 18F-labeled Diaryl\u2010Substituted Dihydropyrrolo[3,2,1\u2010hi]indole as Potential Probe for Functional Imaging of Cyclooxygenase\u20102 with PET. ChemistrySelect. 2016;1(18):5812\u201320. https:\/\/doi.org\/10.1002\/slct.201601618.","journal-title":"ChemistrySelect"},{"issue":"19","key":"3570_CR42","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1016\/j.bmcl.2005.06.080","volume":"15","author":"VJ Majo","year":"2005","unstructured":"Majo VJ, Prabhakaran J, Simpson NR, Van Heertum RL, Mann JJ, Dileep Kumar JS. A general method for the synthesis of aryl [11C]methylsulfones: Potential PET probes for imaging cyclooxygenase-2 expression. Bioorg Med Chem Lett. 2005;15(19):4268\u201371. https:\/\/doi.org\/10.1016\/j.bmcl.2005.06.080.","journal-title":"Bioorg Med Chem Lett"},{"issue":"23\u201324","key":"3570_CR43","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1016\/j.bmcl.2018.10.049","volume":"28","author":"JSD Kumar","year":"2018","unstructured":"Kumar JSD, Zanderigo F, Prabhakaran J, Rubin-Falcone H, Parsey RV, Mann JJ. In vivo evaluation of [11C]TMI, a COX-2 selective PET tracer, in baboons. Bioorg Med Chem Lett. 2018;28(23\u201324):3592\u20135. https:\/\/doi.org\/10.1016\/j.bmcl.2018.10.049.","journal-title":"Bioorg Med Chem Lett"},{"issue":"14","key":"3570_CR44","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1016\/j.bmcl.2018.06.015","volume":"28","author":"J Prabhakaran","year":"2018","unstructured":"Prabhakaran J, Underwood M, Zanderigo F, Simpson NR, Cooper AR, Matthew J, et al. Radiosynthesis and in vivo evaluation of [11C]MOV as a PET imaging agent for COX-2. Bioorg Med Chem Lett. 2018;28(14):2432\u20135. https:\/\/doi.org\/10.1016\/j.bmcl.2018.06.015.","journal-title":"Bioorg Med Chem Lett"},{"issue":"21","key":"3570_CR45","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1016\/j.bmcl.2005.07.065","volume":"15","author":"T Toyokuni","year":"2005","unstructured":"Toyokuni T, Dileep Kumar JS, Walsh JC, Shapiro A, Talley JJ, Phelps ME, et al. Synthesis of 4-(5-[18F]fluoromethyl-3-phenylisoxazol-4-yl)benzenesulfonamide, a new [18F]fluorinated analogue of valdecoxib, as a potential radiotracer for imaging cyclooxygenase-2 with positron emission tomography. Bioorg Med Chem Lett. 2005;15(21):4699\u2013702. https:\/\/doi.org\/10.1016\/j.bmcl.2005.07.065.","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"3570_CR46","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1039\/b412871k","volume":"3","author":"FR W\u00fcst","year":"2005","unstructured":"W\u00fcst FR, H\u00f6hne A, Metz P. Synthesis of 18F-labelled cyclooxygenase-2 (COX-2) inhibitors via Stille reaction with 4-[18F]fluoroiodobenzene as radiotracers for positron emission tomography (PET). Org Biomol Chem. 2005;3(3):503\u20137. https:\/\/doi.org\/10.1039\/b412871k.","journal-title":"Org Biomol Chem"},{"issue":"1","key":"3570_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nucmedbio.2007.07.015","volume":"35","author":"EFJ de Vries","year":"2008","unstructured":"de Vries EFJ, Doorduin J, Dierckx RA, van Waarde A. Evaluation of [11C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation. Nucl Med Biol. 2008;35(1):35\u201342. https:\/\/doi.org\/10.1016\/j.nucmedbio.2007.07.015.","journal-title":"Nucl Med Biol"},{"issue":"10","key":"3570_CR48","first-page":"1700","volume":"44","author":"EFJ de Vries","year":"2003","unstructured":"de Vries EFJ, van Waarde A, Buursma AR, Vaalburg W. Synthesis and In Vivo Evaluation of 18F-Desbromo-DuP-697 as a PET Tracer for Cyclooxygenase-2 Expression. J Nucl Med. 2003;44(10):1700.","journal-title":"J Nucl Med"},{"issue":"16","key":"3570_CR49","doi-asserted-by":"publisher","first-page":"7662","DOI":"10.1016\/j.bmc.2008.07.016","volume":"16","author":"F Wuest","year":"2008","unstructured":"Wuest F, Kniess T, Bergmann R, Pietzsch J. Synthesis and evaluation in vitro and in vivo of a 11C-labeled cyclooxygenase-2 (COX-2) inhibitor. Bioorg Med Chem. 2008;16(16):7662\u201370. https:\/\/doi.org\/10.1016\/j.bmc.2008.07.016.","journal-title":"Bioorg Med Chem"},{"issue":"12","key":"3570_CR50","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2967\/jnumed.118.211144","volume":"59","author":"M-J Kim","year":"2018","unstructured":"Kim M-J, Shrestha SS, Cortes M, Singh P, Morse C, Liow J-S, et al. Evaluation of Two Potent and Selective PET Radioligands to Image COX-1 and COX-2 in Rhesus Monkeys. J Nucl Med. 2018;59(12):1907\u201312. https:\/\/doi.org\/10.2967\/jnumed.118.211144.","journal-title":"J Nucl Med"},{"issue":"1","key":"3570_CR51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1021\/acs.molpharmaceut.9b00986","volume":"17","author":"M Litchfield","year":"2019","unstructured":"Litchfield M, Wuest M, Glubrecht D, Wuest F. Radiosynthesis and Biological Evaluation of [18F]Triacoxib: A New Radiotracer for PET Imaging of COX-2. Mol Pharm. 2019;17(1):251\u201361. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00986.","journal-title":"Mol Pharm"},{"issue":"11","key":"3570_CR52","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1021\/acschemneuro.8b00102","volume":"9","author":"P Singh","year":"2018","unstructured":"Singh P, Shrestha S, Cortes-Salva MY, Jenko KJ, Zoghbi SS, Morse CL, et al. 3-Substituted 1,5-Diaryl-1H-1,2,4-triazoles as Prospective PET Radioligands for Imaging Brain COX-1 in Monkey. Part 1: Synthesis and Pharmacology. ACS Chem Neurosci. 2018;9(11):2610\u20139. https:\/\/doi.org\/10.1021\/acschemneuro.8b00102.","journal-title":"ACS Chem Neurosci"},{"issue":"11","key":"3570_CR53","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1021\/acschemneuro.8b00103","volume":"9","author":"S Shrestha","year":"2018","unstructured":"Shrestha S, Singh P, Cortes-Salva MY, Jenko KJ, Ikawa M, Kim M-J, et al. 3-Substituted 1,5-Diaryl-1H-1,2,4-triazoles as Prospective PET Radioligands for Imaging Brain COX-1 in Monkey. Part 2: Selection and Evaluation of [11C]PS13 for Quantitative Imaging. ACS Chem Neurosci. 2018;9(11):2620\u20137. https:\/\/doi.org\/10.1021\/acschemneuro.8b00103.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"3570_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2967\/jnumed.122.264061","volume":"64","author":"M-J Kim","year":"2023","unstructured":"Kim M-J, Anaya FJ, Manly LS, Lee J-H, Hong J, Shrestha S, et al. Whole-Body PET Imaging in Humans Shows That11C-PS13 Is Selective for Cyclooxygenase-1 and Can Measure the In Vivo Potency of Nonsteroidal Antiinflammatory Drugs. J Nucl Med. 2023;64(1):159\u201364. https:\/\/doi.org\/10.2967\/jnumed.122.264061.","journal-title":"J Nucl Med"},{"key":"3570_CR55","doi-asserted-by":"publisher","unstructured":"Bhardwaj A, Kaur J, Wuest M, Wuest F. In situ click chemistry generation of cyclooxygenase-2 inhibitors. Nat Commun. 2017;8(1). https:\/\/doi.org\/10.1038\/s41467-016-0009-6.","DOI":"10.1038\/s41467-016-0009-6"},{"issue":"46","key":"3570_CR56","doi-asserted-by":"publisher","first-page":"8052","DOI":"10.1039\/C3OB41935E","volume":"11","author":"O Tietz","year":"2013","unstructured":"Tietz O, Sharma SK, Kaur J, Way J, Marshall A, Wuest M, et al. Synthesis of three 18F-labelled cyclooxygenase-2 (COX-2) inhibitors based on a pyrimidine scaffold. Org Biomol Chem. 2013;11(46):8052\u201364. https:\/\/doi.org\/10.1039\/C3OB41935E.","journal-title":"Org Biomol Chem"},{"key":"3570_CR57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nucmedbio.2018.05.001","volume":"62\u201363","author":"O Tietz","year":"2018","unstructured":"Tietz O, Marshall A, Bergman C, Wuest M, Wuest F. Impact of structural alterations on the radiopharmacological profile of 18F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents. Nucl Med Biol. 2018;62\u201363:9\u201317. https:\/\/doi.org\/10.1016\/j.nucmedbio.2018.05.001.","journal-title":"Nucl Med Biol"},{"issue":"1","key":"3570_CR58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13550-016-0192-9","volume":"6","author":"O Tietz","year":"2016","unstructured":"Tietz O, Wuest M, Marshall A, Glubrecht D, Hamann I, Wang M, et al. PET imaging of cyclooxygenase-2 (COX-2) in a pre-clinical colorectal cancer model. EJNMMI Res. 2016;6(1):37. https:\/\/doi.org\/10.1186\/s13550-016-0192-9.","journal-title":"EJNMMI Res"},{"issue":"6","key":"3570_CR59","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.bmcl.2016.02.029","volume":"26","author":"O Tietz","year":"2016","unstructured":"Tietz O, Dzandzi J, Bhardwaj A, Valliant JF, Wuest F. Design and synthesis of [125I]Pyricoxib: A novel 125I-labeled cyclooxygenase-2 (COX-2) inhibitors. Bioorg Med Chem Lett. 2016;26(6):1516\u201320. https:\/\/doi.org\/10.1016\/j.bmcl.2016.02.029.","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"3570_CR60","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12974-020-01804-6","volume":"17","author":"S Shrestha","year":"2020","unstructured":"Shrestha S, Kim M-J, Eldridge M, Lehmann ML, Frankland M, Liow J-S, et al. PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study. J Neuroinflamm. 2020;17(1):140. https:\/\/doi.org\/10.1186\/s12974-020-01804-6.","journal-title":"J Neuroinflamm"},{"issue":"3","key":"3570_CR61","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2967\/jnumed.124.268525","volume":"66","author":"X Yan","year":"2025","unstructured":"Yan X, Noergaard M, Morse CL, Liow J-S, Hong J, Greve D, et al. PET Quantification in Healthy Humans of Cyclooxygenase-2, a Potential Biomarker of Neuroinflammation. J Nucl Med. 2025;66(3):398. https:\/\/doi.org\/10.2967\/jnumed.124.268525.","journal-title":"J Nucl Med"},{"key":"3570_CR62","doi-asserted-by":"publisher","unstructured":"Cortes-Salva MY, Shrestha S, Singh P, Morse CL, Jenko KJ, Montero Santamaria JA, et al. 2-(4-Methylsulfonylphenyl)pyrimidines as Prospective Radioligands for Imaging Cyclooxygenase-2 with PET\u2014Synthesis, Triage, and Radiolabeling. Molecules. 2018;23(11). https:\/\/doi.org\/10.3390\/molecules23112850.","DOI":"10.3390\/molecules23112850"},{"issue":"5","key":"3570_CR63","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1021\/acscentsci.3c01564","volume":"10","author":"MS Placzek","year":"2024","unstructured":"Placzek MS, Wilton DK, We\u00efwer M, Manter MA, Reid SE, Meyer CJ, et al. A Fast-Binding, Functionally Reversible, COX-2 Radiotracer for CNS PET Imaging. ACS Cent Sci. 2024;10(5):1105\u201314. https:\/\/doi.org\/10.1021\/acscentsci.3c01564.","journal-title":"ACS Cent Sci"},{"issue":"7","key":"3570_CR64","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/jlcr.1074","volume":"49","author":"H Tian","year":"2006","unstructured":"Tian H, Lee Z. Synthesis of 18F-labeled cyclooxygenase\u20102 (COX\u20102) inhibitor as a potential PET imaging agent. J Label Compd Radiopharm. 2006;49(7):583\u201393. https:\/\/doi.org\/10.1002\/jlcr.1074.","journal-title":"J Label Compd Radiopharm"},{"issue":"1","key":"3570_CR65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1248\/bpb.b21-00608","volume":"45","author":"Y Yamamoto","year":"2022","unstructured":"Yamamoto Y, Tago T, Toyohara J, Saito Y, Yamamoto F. Radiosynthesis and in Vivo and ex Vivo Evaluation of Isomeric [11C]methoxy Analogs of Nimesulide as Brain Cyclooxygenase-2-Targeted Imaging Agents. Biol Pharm Bull. 2022;45(1):94\u2013103. https:\/\/doi.org\/10.1248\/bpb.b21-00608.","journal-title":"Biol Pharm Bull"},{"issue":"8","key":"3570_CR66","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1248\/cpb.59.938","volume":"59","author":"Y Yamamoto","year":"2011","unstructured":"Yamamoto Y, Toyohara J, Ishiwata K, Sano K, Yamamoto F, Mukai T, et al. 11C-Labeled Analogs of Indomethacin Esters and Amides for Brain Cyclooxygenase-2 Imaging: Radiosynthesis, in Vitro Evaluation and in Vivo Characteristics in Mice. Chem Pharm Bull. 2011;59(8):938\u201346. https:\/\/doi.org\/10.1248\/cpb.59.938.","journal-title":"Chem Pharm Bull"},{"key":"3570_CR67","doi-asserted-by":"publisher","unstructured":"Zlatopolskiy BD, Kandler R, Kobus D, Mottaghy FM, Neumaier B. Beyond azide\u2013alkyne click reaction: easy access to 18F-labelled compounds via nitrile oxide cycloadditions. Chem Commun. 2012;48(57). https:\/\/doi.org\/10.1039\/c2cc31335a.","DOI":"10.1039\/c2cc31335a"},{"issue":"28","key":"3570_CR68","doi-asserted-by":"publisher","first-page":"23126","DOI":"10.1039\/c5ra26323a","volume":"6","author":"K Chansaenpak","year":"2016","unstructured":"Chansaenpak K, Wang M, Liu S, Wu Z, Yuan H, Conti PS, et al. Synthesis and in vivo stability studies of [18F]-zwitterionic phosphonium aryltrifluoroborate\/indomethacin conjugates. RSC Adv. 2016;6(28):23126\u201333. https:\/\/doi.org\/10.1039\/c5ra26323a.","journal-title":"RSC Adv"},{"issue":"9","key":"3570_CR69","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/jlcr.1615","volume":"52","author":"MJ Uddin","year":"2009","unstructured":"Uddin MJ, Crews BC, Blobaum AL, Kingsley PJ, Ghebreselasie K, Saleh SS, et al. Synthesis and evaluation of [123I]-indomethacin derivatives as COX-2 targeted imaging agents. J Label Compd Radiopharm. 2009;52(9):387\u201393. https:\/\/doi.org\/10.1002\/jlcr.1615.","journal-title":"J Label Compd Radiopharm"},{"issue":"11","key":"3570_CR70","doi-asserted-by":"publisher","first-page":"18059","DOI":"10.18632\/oncotarget.15437","volume":"8","author":"A Morgenroth","year":"2017","unstructured":"Morgenroth A, Vogg ATJ, Neumaier B, Mottaghy FM, Zlatopolskiy BD. Radioiodinated indomethacin amide for molecular imaging of cyclooxygenase-2 expressing tumors. Oncotarget. 2017;8(11):18059\u201369.","journal-title":"Oncotarget"},{"issue":"14","key":"3570_CR71","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1002\/chem.200903044","volume":"16","author":"M Takashima-Hirano","year":"2010","unstructured":"Takashima-Hirano M, Shukuri M, Takashima T, Goto M, Wada Y, Watanabe Y, et al. General Method for the 11C\u2010Labeling of 2\u2010Arylpropionic Acids and Their Esters: Construction of a PET Tracer Library for a Study of Biological Events Involved in COXs Expression. Chem \u2013 Eur J. 2010;16(14):4250\u20138. https:\/\/doi.org\/10.1002\/chem.200903044.","journal-title":"Chem \u2013 Eur J"},{"issue":"7","key":"3570_CR72","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.2967\/jnumed.110.084046","volume":"52","author":"M Shukuri","year":"2011","unstructured":"Shukuri M, Takashima-Hirano M, Tokuda K, Takashima T, Matsumura K, Inoue O, et al. In Vivo Expression of Cyclooxygenase-1 in Activated Microglia and Macrophages During Neuroinflammation Visualized by PET with 11C-Ketoprofen Methyl Ester. J Nucl Med. 2011;52(7):1094\u2013101. https:\/\/doi.org\/10.2967\/jnumed.110.084046.","journal-title":"J Nucl Med"},{"issue":"45","key":"3570_CR73","doi-asserted-by":"publisher","first-page":"5908","DOI":"10.1016\/j.tetlet.2010.09.007","volume":"51","author":"K Kato","year":"2010","unstructured":"Kato K, Kikuchi T, Nengaki N, Arai T, Zhang M-R. Tetrabutylammonium fluoride-promoted \u03b1-[11C]methylation of \u03b1-arylesters: a simple and robust method for the preparation of 11C-labeled ibuprofen. Tetrahedron Lett. 2010;51(45):5908\u201311. https:\/\/doi.org\/10.1016\/j.tetlet.2010.09.007.","journal-title":"Tetrahedron Lett"},{"issue":"10","key":"3570_CR74","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1016\/j.bmc.2011.03.041","volume":"19","author":"T Kikuchi","year":"2011","unstructured":"Kikuchi T, Okada M, Nengaki N, Furutsuka K, Wakizaka H, Okamura T, et al. Efficient synthesis and chiral separation of 11C-labeled ibuprofen assisted by DMSO for imaging of in vivo behavior of the individual isomers by positron emission tomography. Bioorg Med Chem. 2011;19(10):3265\u201373. https:\/\/doi.org\/10.1016\/j.bmc.2011.03.041.","journal-title":"Bioorg Med Chem"},{"issue":"13","key":"3570_CR75","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1016\/j.biomaterials.2013.01.050","volume":"34","author":"H-L Huang","year":"2013","unstructured":"Huang H-L, Yeh C-N, Lee W-Y, Huang Y-C, Chang K-W, Lin K-J, et al. [123I]Iodooctyl fenbufen amide as a SPECT tracer for imaging tumors that over-express COX enzymes. Biomaterials. 2013;34(13):3355\u201365. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.01.050.","journal-title":"Biomaterials"},{"key":"3570_CR76","doi-asserted-by":"publisher","unstructured":"Huang Y-C, Chang Y-C, Yeh C-N, Yu C-S. Synthesis and Biological Evaluation of an 18Fluorine-Labeled COX Inhibitor\u2014[18F]Fluorooctyl Fenbufen Amide\u2014For Imaging of Brain Tumors. Molecules. 2016;21(3). https:\/\/doi.org\/10.3390\/molecules21030387.","DOI":"10.3390\/molecules21030387"},{"key":"3570_CR77","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ejps.2017.07.019","volume":"107","author":"C-N Yeh","year":"2017","unstructured":"Yeh C-N, Chang C-W, Chung Y-H, Tien S-W, Chen Y-R, Chen T-W, et al. Synthesis and characterization of boron fenbufen and its F-18 labeled homolog for boron neutron capture therapy of COX-2 overexpressed cholangiocarcinoma. Eur J Pharm Sci. 2017;107:217\u201329. https:\/\/doi.org\/10.1016\/j.ejps.2017.07.019.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"3570_CR78","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/jccs.201700300","volume":"65","author":"YC Huang","year":"2018","unstructured":"Huang YC, Farn SS, Chou YC, Yeh CN, Chang CW, Chung YH, et al. Synthesis of para-[18F]Fluorofenbufen Octylamide for PET Imaging of Brain Tumors. J Chin Chem Soc. 2018;65(6):780\u201392. https:\/\/doi.org\/10.1002\/jccs.201700300.","journal-title":"J Chin Chem Soc"},{"issue":"9","key":"3570_CR79","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1002\/slct.201904788","volume":"5","author":"MM Kiseleva","year":"2020","unstructured":"Kiseleva MM, Vaulina DD, Sivak KV, Alexandrov AG, Kuzmich NN, Viktorov NB, et al. Radiosynthesis of a Novel 11C-Labeled Derivative of 4\u2019\u2010O\u2010Methylhonokiol and Its Preliminary Evaluation in an LPS Rat Model of Neuroinflammation. ChemistrySelect. 2020;5(9):2685\u20139. https:\/\/doi.org\/10.1002\/slct.201904788.","journal-title":"ChemistrySelect"},{"key":"3570_CR80","doi-asserted-by":"publisher","unstructured":"Vaulina DD, Stosman KI, Sivak KV, Aleksandrov AG, Viktorov NB, Kuzmich NN, et al. Preliminary Assessment of the Anti-inflammatory Activity of New Structural Honokiol Analogs with a 4\u2032-O-(2-Fluoroethyl) Moiety and the Potential of Their 18F-Labeled Derivatives for Neuroinflammation Imaging. Molecules. 2021;26(21). https:\/\/doi.org\/10.3390\/molecules26216630.","DOI":"10.3390\/molecules26216630"},{"issue":"8","key":"3570_CR81","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.nucmedbio.2009.07.006","volume":"36","author":"Y Kuge","year":"2009","unstructured":"Kuge Y, Obokata N, Kimura H, Katada Y, Temma T, Sugimoto Y, et al. Synthesis and evaluation of a radioiodinated lumiracoxib derivative for the imaging of cyclooxygenase-2 expression. Nucl Med Biol. 2009;36(8):869\u201376. https:\/\/doi.org\/10.1016\/j.nucmedbio.2009.07.006.","journal-title":"Nucl Med Biol"},{"issue":"2","key":"3570_CR82","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.nucmedbio.2010.08.005","volume":"38","author":"D Petroni","year":"2011","unstructured":"Petroni D, Menichetti L, Sorace O, Poli M, Vanasia M, Salvadori PA. [11C]diclofenac sodium: synthesis and PET assessment of transdermal penetration. Nucl Med Biol. 2011;38(2):181\u20139. https:\/\/doi.org\/10.1016\/j.nucmedbio.2010.08.005.","journal-title":"Nucl Med Biol"},{"issue":"7","key":"3570_CR83","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.nucmedbio.2014.04.008","volume":"41","author":"A Ohnishi","year":"2014","unstructured":"Ohnishi A, Senda M, Yamane T, Sasaki M, Mikami T, Nishio T, et al. Human whole-body biodistribution and dosimetry of a new PET tracer, [11C]ketoprofen methyl ester, for imagings of neuroinflammation. Nucl Med Biol. 2014;41(7):594\u20139. https:\/\/doi.org\/10.1016\/j.nucmedbio.2014.04.008.","journal-title":"Nucl Med Biol"},{"issue":"7","key":"3570_CR84","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nucmedbio.2016.04.005","volume":"43","author":"A Ohnishi","year":"2016","unstructured":"Ohnishi A, Senda M, Yamane T, Mikami T, Nishida H, Nishio T, et al. Exploratory human PET study of the effectiveness of 11C-ketoprofen methyl ester, a potential biomarker of neuroinflammatory processes in Alzheimer\u2019s disease. Nucl Med Biol. 2016;43(7):438\u201344. https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.04.005.","journal-title":"Nucl Med Biol"},{"issue":"5","key":"3570_CR85","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s11307-016-1039-5","volume":"19","author":"S Nozaki","year":"2017","unstructured":"Nozaki S, Ozaki N, Suzuki S, Goto M, Mawatari A, Nakatani Y, et al. Development of Diagnostic Techniques for Early Rheumatoid Arthritis Using Positron Emission Tomography with [11C]PK11195 and [11C]Ketoprofen Tracers. Mol Imaging Biology. 2017;19(5):746\u201353. https:\/\/doi.org\/10.1007\/s11307-016-1039-5.","journal-title":"Mol Imaging Biology"},{"key":"3570_CR86","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nsb1196-927","volume":"3","author":"C Luong","year":"1996","unstructured":"Luong C, et al. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol. 1996;3:927\u201333. https:\/\/doi.org\/10.1038\/nsb1196-927.","journal-title":"Nat Struct Biol"},{"issue":"3","key":"3570_CR87","first-page":"254","volume":"52","author":"MC Giron","year":"2008","unstructured":"Giron MC, Portolan S, Bin A, Mazzi U, Cutler CS. Cytochrome P450 and radiopharmaceutical metabolism.The Quarterly. J Nuclear Med Mol Imaging. 2008;52(3):254\u201366.","journal-title":"J Nuclear Med Mol Imaging"},{"key":"3570_CR88","doi-asserted-by":"publisher","first-page":"1404938","DOI":"10.3389\/fphar.2024.1404938","volume":"15","author":"M Albadry","year":"2024","unstructured":"Albadry M, K\u00fcttner J, Grzegorzewski J, Dirsch O, Kindler E, Klopfleisch R, Liska V, Moulisova V, Nickel S, Palek R, Rosendorf J, Saalfeld S, Settmacher U, Tautenhahn HM, K\u00f6nig M, Dahmen U. Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4. Front Pharmacol. 2024;15:1404938. https:\/\/doi.org\/10.3389\/fphar.2024.1404938.","journal-title":"Front Pharmacol"},{"issue":"9","key":"3570_CR89","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1292\/jvms.09-0449","volume":"72","author":"SK Kim","year":"2010","unstructured":"Kim SK, Choi JW, Hwang IK, Yoo DY, Yoo KY, Lee CH, Choi JH, Shin HC, Seong JK, Yoon YS, Won MH. Species-difference of cyclooxygenase-2 in the hippocampus of rodents. J Vet Med Sci. 2010;72(9):1153\u20138. https:\/\/doi.org\/10.1292\/jvms.09-0449.","journal-title":"J Vet Med Sci"},{"issue":"8","key":"3570_CR90","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.2967\/jnumed.125.270069","volume":"66","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhang X, Wang X, Liu Y, Zhang J, Cui M. Interspecies Variability in Biodistribution and PET Imaging Performance of [18F]Di-PyL: A Dimeric, PSMA-Targeted PET Agent for Prostate Cancer. J Nucl Med. 2025;66(8):1271. https:\/\/doi.org\/10.2967\/jnumed.125.270069.","journal-title":"J Nucl Med"},{"issue":"4","key":"3570_CR91","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1021\/acs.molpharmaceut.5c01912","volume":"23","author":"C Paul","year":"2026","unstructured":"Paul C, Klauser L, Wang. Covalent radiopharmaceuticals: precision imaging and therapy for cancer. Mol Pharm. 2026;23(4):2246\u201355. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c01912.","journal-title":"Mol Pharm"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03570-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03570-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03570-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T06:48:44Z","timestamp":1779778124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-026-03570-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":91,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["3570"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03570-1","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}